NEFL and Alzheimer disease: In conclusion, our study revealed that plasma levels of Aβ42, p-tau181, and NfL are reliable indicators capable of reflecting changes in CSF, and in combination, they can accurately identify preclinical AD at least 8 years prior to symptom onset in Chinese populations.